tiprankstipranks
ChemoMetec A/S (DE:CHY)
FRANKFURT:CHY
Germany Market

ChemoMetec A/S (CHY) Ratios

7 Followers

ChemoMetec A/S Ratios

DE:CHY's free cash flow for Q4 2026 was kr0.64. For the 2026 fiscal year, DE:CHY's free cash flow was decreased by kr and operating cash flow was kr0.50. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Jun 24Jun 23
Liquidity Ratios
Current Ratio
4.09 4.09 3.70 4.97 4.13
Quick Ratio
3.11 3.11 2.95 3.76 3.19
Cash Ratio
2.26 2.26 2.33 3.01 2.66
Solvency Ratio
1.60 1.60 1.28 1.31 1.54
Operating Cash Flow Ratio
1.64 1.64 1.41 1.31 1.29
Short-Term Operating Cash Flow Coverage
137.58 137.58 141.60 96.92 152.47
Net Current Asset Value
kr 389.30Mkr 389.30Mkr 388.47Mkr 378.44Mkr 367.73M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 <0.01 <0.01 <0.01 0.01
Debt-to-Equity Ratio
<0.01 <0.01 <0.01 <0.01 0.01
Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.19 1.19 1.23 1.20 1.23
Debt Service Coverage Ratio
81.94 109.08 92.90 96.62 92.28
Interest Coverage Ratio
238.59 640.29 396.92 976.95 210.03
Debt to Market Cap
<0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
0.32 0.29 0.40 0.25 0.47
Net Debt to EBITDA
-1.07 -1.07 -1.35 -1.56 -1.26
Profitability Margins
Gross Profit Margin
64.30%64.30%93.93%90.13%88.97%
EBIT Margin
49.49%50.58%47.73%43.34%52.08%
EBITDA Margin
52.41%52.03%49.98%45.75%55.22%
Operating Profit Margin
49.11%49.11%49.98%43.83%51.42%
Pretax Profit Margin
50.52%50.52%48.43%43.29%51.84%
Net Profit Margin
39.49%39.49%37.61%33.41%40.20%
Continuous Operations Profit Margin
39.49%39.49%37.61%33.41%40.20%
Net Income Per EBT
78.18%78.18%77.66%77.18%77.56%
EBT Per EBIT
102.86%102.86%96.90%98.77%100.81%
Return on Assets (ROA)
23.44%23.44%22.51%20.14%27.15%
Return on Equity (ROE)
29.29%27.82%27.68%24.11%33.52%
Return on Capital Employed (ROCE)
34.26%34.26%36.37%30.92%42.41%
Return on Invested Capital (ROIC)
26.69%26.69%28.10%23.74%32.68%
Return on Tangible Assets
30.92%30.92%27.62%23.41%30.89%
Earnings Yield
2.35%3.20%1.83%2.60%2.20%
Efficiency Ratios
Receivables Turnover
5.15 5.15 6.22 5.90 7.44
Payables Turnover
4.79 4.79 1.87 3.63 2.79
Inventory Turnover
1.45 1.45 0.27 0.34 0.44
Fixed Asset Turnover
4.04 4.04 4.29 4.43 5.37
Asset Turnover
0.59 0.59 0.60 0.60 0.68
Working Capital Turnover Ratio
1.35 1.29 1.26 1.07 1.51
Cash Conversion Cycle
247.25 247.25 1.19K 1.04K 757.20
Days of Sales Outstanding
70.85 70.85 58.64 61.82 49.07
Days of Inventory Outstanding
252.54 252.53 1.33K 1.08K 838.83
Days of Payables Outstanding
76.13 76.13 195.22 100.46 130.70
Operating Cycle
323.38 323.38 1.39K 1.14K 887.90
Cash Flow Ratios
Operating Cash Flow Per Share
12.09 12.09 11.92 7.41 8.86
Free Cash Flow Per Share
10.47 10.46 10.20 4.91 6.51
CapEx Per Share
1.63 1.63 1.72 2.50 2.35
Free Cash Flow to Operating Cash Flow
0.87 0.87 0.86 0.66 0.74
Dividend Paid and CapEx Coverage Ratio
1.39 1.39 2.09 0.87 3.78
Capital Expenditure Coverage Ratio
7.43 7.43 6.95 2.96 3.78
Operating Cash Flow Coverage Ratio
45.84 45.84 32.39 31.05 21.53
Operating Cash Flow to Sales Ratio
0.41 0.41 0.42 0.32 0.35
Free Cash Flow Yield
2.12%2.89%1.75%1.63%1.40%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
42.48 31.22 54.58 38.49 45.39
Price-to-Sales (P/S) Ratio
16.78 12.33 20.53 12.86 18.25
Price-to-Book (P/B) Ratio
11.82 8.69 15.11 9.28 15.21
Price-to-Free Cash Flow (P/FCF) Ratio
47.11 34.62 57.28 61.37 71.56
Price-to-Operating Cash Flow Ratio
40.75 29.96 49.03 40.66 52.61
Price-to-Earnings Growth (PEG) Ratio
5.11 3.76 1.48 -1.62 3.75
Price-to-Fair Value
11.82 8.69 15.11 9.28 15.21
Enterprise Value Multiple
30.95 22.63 39.71 26.55 31.79
Enterprise Value
8.29B 6.02B 9.84B 4.95B 7.80B
EV to EBITDA
30.95 22.63 39.71 26.55 31.79
EV to Sales
16.22 11.77 19.85 12.14 17.55
EV to Free Cash Flow
45.54 33.05 55.39 57.95 68.83
EV to Operating Cash Flow
39.41 28.60 47.42 38.40 50.60
Tangible Book Value Per Share
29.73 29.73 29.90 27.05 26.05
Shareholders’ Equity Per Share
41.70 41.69 38.69 32.48 30.63
Tax and Other Ratios
Effective Tax Rate
0.22 0.22 0.22 0.23 0.22
Revenue Per Share
29.38 29.37 28.48 23.44 25.54
Net Income Per Share
11.60 11.60 10.71 7.83 10.27
Tax Burden
0.78 0.78 0.78 0.77 0.78
Interest Burden
1.02 1.00 1.01 1.00 1.00
Research & Development to Revenue
0.03 0.03 0.02 0.02 0.02
SG&A to Revenue
0.12 0.12 0.42 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
1.04 0.84 1.11 0.95 0.67
Currency in DKK